Compare GFL Environmental Inc. Subordinate voting shares no par value (GFL) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GFL Environmental Inc. Subordinate voting shares no par value vs Moderna, Inc. — how do they compare? GFL Environmental Inc. Subordinate voting shares no par value trades at $42.63 (market cap $18.46B), while Moderna, Inc. trades at $218.26 (market cap $78.65B). The key difference: Moderna, Inc. is far larger — about 4.3× GFL Environmental Inc. Subordinate voting shares no par value's market cap, and GFL Environmental Inc. Subordinate voting shares no par value pays a 0.16% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold GFL Environmental Inc. Subordinate voting shares no par value for 0 Days and Moderna, Inc. for 59 Days on average.
| GFL | MRNA | |
|---|---|---|
Market Cap | $18.46B | $78.65B |
Volume | 2,438,353 | 37,373,437 |
Sector | Industrials | Health |
52-Week High | $46.51 | $203.46 |
52-Week Low | $33.54 | $22.36 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $25.43B | $74.80B |
Dividend Yield | 0.16% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $214.50, up 9.17% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics, with revenue declining from $18.9B in 2022 to $1.92B in 2025. Recent Nasdaq-100 inclusion creates institutional demand, though Citigroup downgraded to Sell citing valuation concerns after a 500% 2026 rally. The company continues beating EPS expectations despite net losses.
Outlook remains bifurcated between technical strength and fundamental challenges. The cancer vaccine pipeline offers growth potential, but persistent losses and high valuations create headwinds. Near-term momentum may continue from index fund inflows, though profitability concerns warrant caution for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GFL Environmental Inc. Subordinate voting shares no par value
GFL Environmental provides environmental services across Canada and the United States. Its operations include solid waste management and other waste and environmental solutions.
Read more on GFL →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
